Zhejiang Hisun Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Kevin Xiao
Chief executive officer
CN¥869.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 5.4yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Kevin Xiao (55 yo)
less than a year
Tenure
CN¥869,500
Compensation
Mr. Weihong Xiao, also known as Kevin, has been Chief Executive Officer at Zhejiang Hisun Pharmaceutical Co., Ltd. since October 11, 2023. He served as Chief Operating Officer at 3SBio Inc. since March 201...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | CN¥869.50k | no data | |
| Senior Vice President | 5.4yrs | CN¥1.13m | 0.018% CN¥ 1.8m | |
| Senior Vice President | 5.4yrs | CN¥1.39m | 0.021% CN¥ 2.1m | |
| Director and Senior Vice President | 5.4yrs | CN¥2.13m | 0.021% CN¥ 2.1m | |
| Secretary of the Board | 7yrs | CN¥825.50k | 0.013% CN¥ 1.3m |
5.4yrs
Average Tenure
50yo
Average Age
Experienced Management: 600267's management team is seasoned and experienced (5.4 years average tenure).